Somerset Therapeutics Ltd. - Research Center
524758 WINTAC Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 20 |
Mar ' 20 |
Sep ' 19 |
Sep ' 18 |
Sep ' 17 |
Sales |
74.97 |
49.72 |
35.39 |
27.27 |
23.72 |
Operating profit |
7.31 |
3.88 |
-1.11 |
-7.98 |
-0.82 |
Interest |
1.24 |
1.39 |
0.52 |
0.78 |
0.40 |
Gross profit |
6.18 |
5.05 |
-1.44 |
-8.24 |
-1.16 |
EPS (Rs) |
1.16 |
0.60 |
-3.66 |
-10.15 |
-3.56 |
Half yearly
results in details
|
Sep ' 20 |
Mar ' 20 |
Sep ' 19 |
Sep ' 18 |
Sep ' 17 |
Other income |
0.11 |
2.57 |
0.19 |
0.52 |
0.06 |
Stock adjustment |
-0.80 |
0.17 |
-0.90 |
-1.90 |
-0.80 |
Raw material |
27.17 |
20.49 |
16.18 |
12.10 |
9.21 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
15.04 |
15.54 |
12.14 |
10.88 |
8.50 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
26.25 |
9.64 |
9.07 |
14.16 |
7.64 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
4.57 |
4.33 |
2.91 |
1.97 |
1.72 |
Taxation |
0.45 |
0.13 |
-0.69 |
-0.03 |
0.68 |
Net profit / loss |
1.16 |
0.60 |
-3.67 |
-10.18 |
-3.57 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.02 |
10.02 |
10.02 |
10.02 |
10.02 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
9.75 |
7.80 |
-3.14 |
-29.24 |
-3.44 |
GPM (%) |
8.23 |
9.67 |
-4.05 |
-29.65 |
-4.90 |
NPM (%) |
1.54 |
1.15 |
-10.30 |
-36.62 |
-15.00 |